Cargando…

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report

Detalles Bibliográficos
Autores principales:	Hodecker, Sibylle C., Stellmann, Jan-Patrick, Rosenkranz, Sina C., Young, Kim, Holst, Brigitte, Friese, Manuel A., Heesen, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2017
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292926/ https://www.ncbi.nlm.nih.gov/pubmed/28203617 http://dx.doi.org/10.1212/NXI.0000000000000328

Ejemplares similares

Maraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MS
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Rituximab during pregnancy in neuromyelitis optica: A case report
por: Miranda-Acuña, Jahir, et al.
Publicado: (2019)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Mortality in neuromyelitis optica is strongly associated with African ancestry
por: Mealy, Maureen A., et al.
Publicado: (2018)

Longitudinally extensive myelitis in MS mimicking neuromyelitis optica
por: Whittam, Daniel, et al.
Publicado: (2017)

Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease
por: Kaku, Michelle, et al.
Publicado: (2016)

Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy
por: Feyissa, Anteneh M., et al.
Publicado: (2015)

Dramatic efficacy of ofatumumab in refractory pediatric-onset AQP4-IgG neuromyelitis optica spectrum disorder
por: Maillart, Elisabeth, et al.
Publicado: (2020)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders
por: Fan, Xueli, et al.
Publicado: (2016)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
por: Stoessel, Daniel, et al.
Publicado: (2018)

Interferon Alpha Association with Neuromyelitis Optica
por: Asgari, Nasrin, et al.
Publicado: (2013)

Neuromyelitis optica with fluorosis: An association or coincidence
por: Arshad, Faheem, et al.
Publicado: (2020)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing–remitting MS
por: Stellmann, Jan‐Patrick, et al.
Publicado: (2016)

Reduced rich-club connectivity is related to disability in primary progressive MS
por: Stellmann, Jan-Patrick, et al.
Publicado: (2017)

Olfactory Dysfunction in Patients with Neuromyelitis Optica
por: Schmidt, Felix, et al.
Publicado: (2013)

Neuromyelitis Optica Spectrum Disorder Associated with Cervical Spondylosis
por: Zhou, Yuan, et al.
Publicado: (2015)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

COVID-19—White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
por: Brun, Gilles, et al.
Publicado: (2020)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

The Gut Microbiome in Neuromyelitis Optica
por: Zamvil, Scott S., et al.
Publicado: (2017)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
por: Jagtap, Sujit Abajirao, et al.
Publicado: (2015)

Neuromyelitis Optica Mimicking Intramedullary Tumor
por: Oh, Si-Hyuck, et al.
Publicado: (2013)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

Multisystem involvement in neuromyelitis optica
por: Langille, Megan M., et al.
Publicado: (2015)

A Case of Neuromyelitis Optica
por: DE, M. N., et al.
Publicado: (1946)

A Case of Neuromyelitis Optica
por: Shone, S.
Publicado: (1940)

Treatment strategies for neuromyelitis optica
por: Huang, Tzu-Lun, et al.
Publicado: (2018)

Cognitive Impairment in Neuromyelitis Optica
por: YABALAK, Ahmet, et al.
Publicado: (2020)

Educational Case: Neuromyelitis optica
por: Kitchens, Nathaniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hts5fvj587dfh98mcissafngro